ALLISON ROSTOCKI: Open Payments
NPI 1396170320 · HAZLETON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 24 payments from 10 companies in 2025. Trend: 2023 $2,746 · 2024 $590 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $338 |
| Boston Scientific Corporation | 1 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $95 |
| SCPHARMACEUTICALS INC. | 3 | $70 |
| Amgen Inc. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
Products named: Ozempic, WATCHMAN FLX, JARDIANCE, Wegovy, FUROSCIX, REPATHA, Kerendia, LEQVIO.
Industry payments across PA — which companies pay providers there.
